These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 34770864)

  • 1. Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders.
    Mishra A; Mishra PS; Bandopadhyay R; Khurana N; Angelopoulou E; Paudel YN; Piperi C
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An updated review on the versatile role of chrysin in neurological diseases: Chemistry, pharmacology, and drug delivery approaches.
    Talebi M; Talebi M; Farkhondeh T; Kopustinskiene DM; Simal-Gandara J; Bernatoniene J; Samarghandian S
    Biomed Pharmacother; 2021 Sep; 141():111906. PubMed ID: 34328092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comprehensive Review on Therapeutic Potential of Chrysin in Brain Related Disorders.
    Goyal A; Singh G; Verma A
    CNS Neurol Disord Drug Targets; 2023; 22(6):789-800. PubMed ID: 35657041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective potential of chrysin in Parkinson's disease: Molecular mechanisms and clinical implications.
    Angelopoulou E; Pyrgelis ES; Piperi C
    Neurochem Int; 2020 Jan; 132():104612. PubMed ID: 31785348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective Effects of Fisetin in Alzheimer's and Parkinson's Diseases: From Chemistry to Medicine.
    Nabavi SF; Braidy N; Habtemariam S; Sureda A; Manayi A; Nabavi SM
    Curr Top Med Chem; 2016; 16(17):1910-5. PubMed ID: 26845554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of naringin in neurological disorders.
    Ahmed S; Khan H; Aschner M; Hasan MM; Hassan STS
    Food Chem Toxicol; 2019 Oct; 132():110646. PubMed ID: 31252025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential benefits of phytochemicals from Azadirachta indica against neurological disorders.
    Sandhir R; Khurana M; Singhal NK
    Neurochem Int; 2021 Jun; 146():105023. PubMed ID: 33753160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Effective and Promising Treatments for Neurological Disorders and Cancer.
    Uteshev VV
    Curr Pharm Des; 2016; 22(14):1979-80. PubMed ID: 26899733
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroprotective effects of chrysin: From chemistry to medicine.
    Nabavi SF; Braidy N; Habtemariam S; Orhan IE; Daglia M; Manayi A; Gortzi O; Nabavi SM
    Neurochem Int; 2015 Nov; 90():224-31. PubMed ID: 26386393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Role of Agmatine in Neurological Diseases.
    Xu W; Gao L; Li T; Shao A; Zhang J
    Curr Neuropharmacol; 2018; 16(9):1296-1305. PubMed ID: 28786346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvacrol as a Potential Neuroprotective Agent for Neurological Diseases: A Systematic Review Article.
    Zamanian MY; Kujawska M; Nikbakhtzadeh M; Hassanshahi A; Ramezanpour S; Kamiab Z; Bazmandegan G
    CNS Neurol Disord Drug Targets; 2021; 20(10):942-953. PubMed ID: 33970850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective Strategies for Neurological Disorders by Natural Products: An update.
    Rehman MU; Wali AF; Ahmad A; Shakeel S; Rasool S; Ali R; Rashid SM; Madkhali H; Ganaie MA; Khan R
    Curr Neuropharmacol; 2019; 17(3):247-267. PubMed ID: 30207234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological Disorders.
    Paudel YN; Angelopoulou E; Semple B; Piperi C; Othman I; Shaikh MF
    ACS Chem Neurosci; 2020 Feb; 11(4):485-500. PubMed ID: 31972087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders.
    Sethiya NK; Ghiloria N; Srivastav A; Bisht D; Chaudhary SK; Walia V; Alam MS
    CNS Neurol Disord Drug Targets; 2024; 23(7):865-882. PubMed ID: 37461364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives.
    Moghadam ER; Ang HL; Asnaf SE; Zabolian A; Saleki H; Yavari M; Esmaeili H; Zarrabi A; Ashrafizadeh M; Kumar AP
    Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32992587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease.
    Braidy N; Behzad S; Habtemariam S; Ahmed T; Daglia M; Nabavi SM; Sobarzo-Sanchez E; Nabavi SF
    CNS Neurol Disord Drug Targets; 2017; 16(4):387-397. PubMed ID: 28474543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives.
    Kasala ER; Bodduluru LN; Madana RM; V AK; Gogoi R; Barua CC
    Toxicol Lett; 2015 Mar; 233(2):214-25. PubMed ID: 25596314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chrysin attenuates global cerebral ischemic reperfusion injury via suppression of oxidative stress, inflammation and apoptosis.
    El Khashab IH; Abdelsalam RM; Elbrairy AI; Attia AS
    Biomed Pharmacother; 2019 Apr; 112():108619. PubMed ID: 30797156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-α-synuclein Toxicity and Anti-neurodegenerative Role of Chrysin in Transgenic
    Muhammad F; Liu Y; Wang N; Zhao L; Zhou Y; Yang H; Li H
    ACS Chem Neurosci; 2022 Feb; 13(4):442-453. PubMed ID: 35118868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.